Related Experiment Video
Updated: May 29, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
HIV/AIDS burden, attributable risk factors, and projections among reproductive-age adults in China, 1990-2035: A GBD
1Clinical Laboratory, Shanghai Putuo District Maternity and Infant Hospital, Shanghai, China.
Insights
China
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- HIV/AIDS remains a significant global health challenge.
- Antiretroviral therapy has made HIV a manageable chronic condition.
- Understanding current HIV/AIDS trends in Chinese reproductive-age adults is crucial for epidemic control.
Purpose of the Study:
- To provide an updated, comprehensive assessment of the HIV/AIDS burden in Chinese reproductive-age adults.
- To analyze contemporary trends and identify attributable risk factors.
- To forecast future HIV/AIDS burden using refined methodologies and post-pandemic data.
Main Methods:
- Extracted age-standardized incidence, prevalence, mortality, and DALYs from GBD 2023 for Chinese adults (15-49 years).
- Utilized Joinpoint regression for trend analysis and ARIMA models for forecasting to 2035.
- Analyzed population attributable fractions for unsafe sex, drug use, and intimate-partner violence.
Main Results:
- Between 1990-2023, age-standardized HIV/AIDS rates increased significantly across all metrics, with males showing steeper rises.
- Unsafe sex was the primary contributor to HIV/AIDS mortality (70% in 2023).
- Projections indicate continued female metric increases and widening sex disparities by 2035.
Conclusions:
- China's HIV epidemic is now a chronic disease burden with significant sex differences.
- Rising mortality, particularly among women, necessitates gender-differentiated prevention strategies.
- Findings support China's National HIV/AIDS Action Plan and SDG 3.3 monitoring.
Background:
HIV/AIDS remains a leading infectious disease burden globally. While highly active antiretroviral therapy has transformed HIV into a manageable chronic condition, contemporary trends and attributable risk factors among reproductive-age adults in China-a critical demographic for epidemic control-remain poorly characterized. This study provides an updated comprehensive assessment of HIV/AIDS burden in this population using Global Burden of Disease Study 2023 data, which incorporates methodological refinements and post-pandemic data not available in earlier versions.
Methods:
We extracted age-standardised incidence, prevalence, mortality and disability-adjusted life-years (DALYs) for Chinese adults aged 15-49 years from GBD 2023. Joinpoint regression estimated annual percent change and identified significant trend inflection points. Population attributable fractions were analysed for unsafe sex, drug use, and intimate-partner violence. ARIMA models forecasted burden trends to 2035 with 95% uncertainty intervals.
Results:
Between 1990 and 2023, age-standardised rates increased substantially: incidence +301% (from 0.82 to 3.29 per 100,000), prevalence +774% (4.84 to 42.29), mortality +1,623% (0.13 to 2.24), and DALYs + 1,439% (7.96 to 122.48). Males showed consistently steeper increases than females across all metrics (all p < 0.05). Unsafe sex accounted for 70% of HIV/AIDS mortality in 2023. ARIMA projections indicate that while male incidence will plateau at ~5.0 per 100,000 by 2035, female metrics will continue rising (incidence +21%, prevalence +30%), widening the sex disparity.
Conclusion:
China's HIV epidemic has transitioned to a chronic disease burden. Notably, this burden shows pronounced sex differences. Mortality is rising among people living with HIV, particularly among women. These trends highlight urgent needs for gender-differentiated prevention strategies. Our findings provide measurable targets for China's National HIV/AIDS Action Plan (2024-2030) and SDG 3.3 monitoring. They further demonstrate how standardized burden estimation supports precision public health.
Related Concept Videos
Amebiasis
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Infectious Diseases and Their Occurrence
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...